CN1291723C - 作为肿瘤相关抗原的伸展1型链鞘糖脂 - Google Patents

作为肿瘤相关抗原的伸展1型链鞘糖脂 Download PDF

Info

Publication number
CN1291723C
CN1291723C CNB008197881A CN00819788A CN1291723C CN 1291723 C CN1291723 C CN 1291723C CN B008197881 A CNB008197881 A CN B008197881A CN 00819788 A CN00819788 A CN 00819788A CN 1291723 C CN1291723 C CN 1291723C
Authority
CN
China
Prior art keywords
cells
tumor
mab
stands
fucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB008197881A
Other languages
English (en)
Chinese (zh)
Other versions
CN1460022A (zh
Inventor
S·莱弗里
S-I·哈克莫利
M·斯特劳德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomembrane Institute
Original Assignee
Biomembrane Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomembrane Institute filed Critical Biomembrane Institute
Publication of CN1460022A publication Critical patent/CN1460022A/zh
Application granted granted Critical
Publication of CN1291723C publication Critical patent/CN1291723C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
CNB008197881A 2000-07-03 2000-07-03 作为肿瘤相关抗原的伸展1型链鞘糖脂 Expired - Lifetime CN1291723C (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/018219 WO2002002127A1 (en) 2000-07-03 2000-07-03 Extended type 1 chain glycosphingolipids as tumor-associated antigens

Publications (2)

Publication Number Publication Date
CN1460022A CN1460022A (zh) 2003-12-03
CN1291723C true CN1291723C (zh) 2006-12-27

Family

ID=21741553

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB008197881A Expired - Lifetime CN1291723C (zh) 2000-07-03 2000-07-03 作为肿瘤相关抗原的伸展1型链鞘糖脂

Country Status (6)

Country Link
EP (1) EP1307207A4 (enExample)
JP (1) JP2004502025A (enExample)
KR (1) KR100666238B1 (enExample)
CN (1) CN1291723C (enExample)
AU (2) AU2000260652B2 (enExample)
WO (1) WO2002002127A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5331293B2 (ja) * 2006-04-28 2013-10-30 公益財団法人野口研究所 多様性を表現するオリゴ糖またはその誘導体
KR101432474B1 (ko) * 2008-09-07 2014-08-21 글라이코넥스 인코포레이티드 항-연장된 ⅰ형 글라이코스핑고지질 항체, 이의 유도체 및 용도
CN104655859B (zh) * 2013-11-21 2017-10-03 苏州中赢医疗科技有限公司 乳腺癌的诊断标志物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083929A (en) * 1991-05-06 2000-07-04 The Biomembrane Institute Extended type 1 chain glycosphingolipids as tumor-associated antigens
WO1992019634A1 (en) * 1991-05-06 1992-11-12 The Biomembrane Institute Extended type 1 chain glycosphingolipids as tumor-associated antigens

Also Published As

Publication number Publication date
JP2004502025A (ja) 2004-01-22
AU2000260652B2 (en) 2005-10-27
EP1307207A1 (en) 2003-05-07
CN1460022A (zh) 2003-12-03
KR20030068120A (ko) 2003-08-19
WO2002002127A1 (en) 2002-01-10
EP1307207A4 (en) 2005-12-14
AU6065200A (en) 2002-01-14
KR100666238B1 (ko) 2007-01-09

Similar Documents

Publication Publication Date Title
Singhal et al. Molecular changes in carbohydrate antigens associated with cancer
Cheresh et al. Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis
Stroud et al. Extended type 1 chain glycosphingolipids: dimeric Lea (III4V4Fuc2Lc6) as human tumor-associated antigen
US5102663A (en) Vaccine for stimulating or enhancing production of antibodies against 9-O-acetyl GD3
Durrant et al. Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy
US5240833A (en) Method for the production of monoclonal antibodies directed to tumor-associated gangliosides and fucogangliosides
EP0381310A1 (en) Monoclonal antibodies directed to tumor-associated gangliosides and fucogangliosides and method for production thereof
Goletz et al. Thomsen-Friedenreich antigen: the “hidden” tumor antigen
US20130108624A1 (en) Cryptic glycan markers and applications thereof
Mårtensson et al. A carbohydrate epitope associated with human squamous lung cancer
US6083929A (en) Extended type 1 chain glycosphingolipids as tumor-associated antigens
CN1291723C (zh) 作为肿瘤相关抗原的伸展1型链鞘糖脂
CN1802387A (zh) 癌症疾病改善抗体
Kannagi et al. Gangliosides and tumors
Ito et al. Specificity and immunobiological properties of monoclonal antibody IMH2, established after immunization with Leb/Lea glycosphingolipid, a novel extended type 1 chain antigen
WO2005012361A2 (en) Antibodies raised against colon carcinomas
JPH07504222A (ja) 化学的に規定されるオリゴ糖,該オリゴ糖の誘導体,擬態物及び該オリゴ糖に対する抗体による細胞接着の抑制
AU659808B2 (en) Inhibition of metastasis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies
AU2000260652A1 (en) Extended type 1 chain glycosphingolipids as tumor-associated antigens
WO1992019634A1 (en) Extended type 1 chain glycosphingolipids as tumor-associated antigens
Yamashita et al. A new cancer‐associated antigen defined by a monoclonal antibody against a synthetic carbohydrate chain
Satoh et al. Glycolipid expression in prostatic tissue and analysis of the antigen recognized by antiprostatic monoclonal antibody APG1
JP2007191490A (ja) 腫瘍関連抗原としての拡張i型スフィンゴ糖脂質鎖
Hanisch et al. Monoclonal antibody FW6 defines an epitope on α3/4-monofucosylated polylactosaminoglycans expressed by fetal and colon carcinoma-associated mucins
EP0521692A2 (en) Inhibition of tumor cell metastasis potential and invasiveness by chemically-defined oligosaccharides, their derivatives, mimetics and antibodies directed to them

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20061227